PROGESTERONE Side Effects

6173594-6 | Abdominal Pain, Acne Cystic, Arthralgia, Back Pain, Complication Of Device Insertion, Feeling Abnormal, Fluid Retention, Gait Disturbance, Hypoaesthesia
on Apr 29, 2009 Female patient from UNITED STATES , weighting 130.0 lb, was treated with Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), acne cystic, arthralgia, back pain (What is back pain?), complication of device insertion, feeling abnormal, fluid retention, gait disturbance, hypoaesthesia. Progesterone dosage: .

6171596-7 | Back Injury, Impaired Healing, Joint Injury, Muscle Rupture, Pain, Soft Tissue Injury
Patient was taking Progesterone (View Usage). Patient had the following side effects: back injury, impaired healing, joint injury, muscle rupture, pain (What is pain?), soft tissue injury on Apr 28, 2009 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 185.0 lb, was diagnosed with menopause (What is menopause?) and. Progesterone dosage: As Rec.

6162567-5 | Blood Testosterone Increased, Breast Tenderness, Loss Of Libido, Mood Altered
Adverse event was reported on Mar 17, 2006 by a Female patient taking Progesterone (View Usage) (Dosage: Daily Dose: 20 Milligram(s) For The First 14 Days Of The Month.) was diagnosed with accidental exposure, ill-defined disorder and. Location: UNITED STATES , 46 years of age, weighting 110.2 lb, After Progesterone was administered, patient had the following side effects: blood testosterone increased, breast tenderness, loss of libido, mood altered. During the same period patient was treated with ANDROGEL (Daily Dose: 5 Gram(s)) (View Androgel Review and Androgel Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), N ACETYL CYSTEINE (View N-acetyl Cysteine Review and N-acetyl Cysteine Label ), ALPHA LIPOIC ACID (View Alpha-lipoic Acid Review and Alpha-lipoic Acid Label ).

6161993-8 | Laboratory Test Interference
on Apr 02, 2008 Female patient from UNITED STATES , 55 years of age, weighting 121.3 lb, was diagnosed with accidental exposure, diabetes mellitus and was treated with Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: laboratory test interference. Progesterone dosage: . During the same period patient was treated with ANDROGEL (Daily Dose: 10 Gram(s)) (View Androgel Review and Androgel Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), INSULIN (View Insulin Review and Insulin Label ).


6072899-7 | Pancreatitis Acute
on Oct 06, 2008 Female patient from UNITED STATES , 55 years of age, was diagnosed with opportunistic infection prophylaxis and was treated with Progesterone (View Usage). Patient had the following side effects: pancreatitis acute. Progesterone dosage: Daily. During the same period patient was treated with ATAZANAVIR SULFATE (Daily) (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), ABACAVIR (Daily) (View Abacavir Review and Abacavir Label ), LAMIVUDINE (Daily) (View Lamivudine Review and Lamivudine Label ), TRIMETHOPRIM SULFAMETHOXAZOLE (Daily) (View Trimethoprim-sulfamethoxazole Review and Trimethoprim-sulfamethoxazole Label ), ESTRADIOL (Daily) (View Estradiol Review and Estradiol Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), HUMAN LANTUS INSULIN (HUMAN LANTUS INSULIN) (View Human Lantus Insulin (human Lantus Insulin) Review and Human Lantus Insulin (human Lantus Insulin) Label ), HUMAN ASPART INSULIN (HUMAN ASPART INSULIN) (View Human Aspart Insulin (human Aspart Insulin) Review and Human Aspart Insulin (human Aspart Insulin) Label ). Patient was hospitalized.

6045434-7 | Arthropod Bite, Auricular Swelling, Ear Disorder, Erythema, Eye Pruritus, Eye Swelling, Lip Swelling, Nasal Disorder
Patient was taking Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: arthropod bite, auricular swelling, ear disorder, erythema, eye pruritus, eye swelling, lip swelling, nasal disorder on Jan 16, 2009 from UNITED STATES Additional patient health information: Female patient , 30 years of age, . Progesterone dosage: 50 Mg Once A Day 5 Or More Injections. During the same period patient was treated with ESTROGEN TABLETS (View Estrogen Tablets Review and Estrogen Tablets Label ).

5930771-4 | Cholestasis, Ovarian Hyperstimulation Syndrome
Adverse event was reported on Oct 15, 2008 by a Female patient taking Progesterone (View Usage) (Dosage: Daily Dose: 600 Milligram(s)) was diagnosed with in vitro fertilisation, insulin resistance and. Location: UNITED STATES , 32 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, ovarian hyperstimulation syndrome. During the same period patient was treated with FOLLICLE STIMULATING HORMONE (Daily Dose: 75 International Unit(s)) (View Follicle Stimulating Hormone Review and Follicle Stimulating Hormone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), HUMAN CHORIONIC GONADOTROPIN (HCG) (View Human Chorionic Gonadotropin (hcg) Review and Human Chorionic Gonadotropin (hcg) Label ).

5737865-7 | Deep Vein Thrombosis, Pulmonary Embolism
on May 12, 2008 Female patient from UNITED STATES , weighting 152.0 lb, was diagnosed with infertility (What is infertility?) and was treated with Progesterone (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Progesterone dosage: 25 Mg Daily Im. During the same period patient was treated with ESTRADIOL (0.1mg Daily Transdermal Patch) (View Estradiol Review and Estradiol Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

5711212-9 | Acute Graft Versus Host Disease In Skin, Conjunctivitis
on Apr 11, 2008 Female patient from ISRAEL , 25 years of age, was diagnosed with amenorrhoea, stem cell transplant and was treated with Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: acute graft versus host disease in skin, conjunctivitis. Progesterone dosage: Daily Dose: 200 Milligram(s). During the same period patient was treated with DONOR LYMPHOCYTE INFUSIONS (View Donor Lymphocyte Infusions Review and Donor Lymphocyte Infusions Label ).

5701691-5 | Abortion Spontaneous, Foetal Heart Rate Abnormal, Haematoma
Patient was taking Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, foetal heart rate abnormal, haematoma on Apr 09, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 190.0 lb, was diagnosed with infertility (What is infertility?) and. Progesterone dosage: Once Daily Im.

5670297-9 | Abortion Induced, Sex Chromosome Abnormality, Uterine Haemorrhage
Adverse event was reported on Mar 11, 2008 by a Female patient taking Progesterone (View Usage) (Dosage: Daily Dose: 800 Milligram(s)) was diagnosed with in vitro fertilisation and. Location: UNITED KINGDOM , 35 years of age, Patient had the following side effects: abortion induced, sex chromosome abnormality, uterine haemorrhage. During the same period patient was treated with PROPOFOL (Daily Dose: 240 Milligram(s)) (View Propofol Review and Propofol Label ), PREGNYL (Daily Dose: 10000 International Unit(s)) (View Pregnyl Review and Pregnyl Label ), LEUPROLIDE ACETATE (Daily Dose: 3.75 Milligram(s)) (View Leuprolide Acetate Review and Leuprolide Acetate Label ), PUREGON (Daily Dose: 150 International Unit(s) For Seven Days) (View Puregon Review and Puregon Label ), ALFENTANIL (Daily Dose: 600 Milligram(s)) (View Alfentanil Review and Alfentanil Label ).

5494674-4 | Fatigue, Headache, Loss Of Consciousness, Nausea
on Oct 23, 2007 Female patient from UNITED STATES , 33 years of age, weighting 122.0 lb, was diagnosed with ovarian cyst (What is ovarian cyst?) and was treated with Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: fatigue, headache (What is headache?), loss of consciousness, nausea (What is nausea?). Progesterone dosage: .

5381006-5 | Retinal Vein Thrombosis
on Jan 08, 2007 Female patient from FRANCE , 60 years of age, was diagnosed with ill-defined disorder and was treated with Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein thrombosis. Progesterone dosage: . During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ). Patient was hospitalized.

5259776-6 | Abortion Induced, Sex Chromosome Abnormality, Uterine Haemorrhage
Patient was taking Progesterone (View Usage). Patient had the following side effects: abortion induced, sex chromosome abnormality, uterine haemorrhage on Feb 26, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 35 years of age, was diagnosed with in vitro fertilisation and. Progesterone dosage: Daily Dose: 800 Milligram(s). During the same period patient was treated with DIPRIVAN (Daily Dose: 240 Milligram(s)) (View Diprivan Review and Diprivan Label ), PREGNYL (Daily Dose: 1000 International Unit(s)) (View Pregnyl Review and Pregnyl Label ), PROSTAP (Daily Dose: 3.75 Milligram(s)) (View Prostap Review and Prostap Label ), PURGEON (Daily Dose: 100 International Unit(s)) (View Purgeon Review and Purgeon Label ), RAPIFEN (Daily Dose: 600 Milligram(s)) (View Rapifen Review and Rapifen Label ).

5243881-4 | Abortion Spontaneous, Eosinophilic Pneumonia, Gastric Disorder, Heart Rate Increased, Laboratory Test Abnormal, Pregnancy, Viral Infection
Adverse event was reported on Feb 20, 2007 by a Female patient taking Progesterone (View Usage) (Dosage: 1 Cc Daily Im) was diagnosed with in vitro fertilisation and. Location: UNITED STATES , 31 years of age, weighting 135.0 lb, After Progesterone was administered, patient had the following side effects: abortion spontaneous, eosinophilic pneumonia, gastric disorder, heart rate increased, laboratory test abnormal, pregnancy (What is pregnancy?), viral infection (What is viral infection?).

5242516-4 | Bone Marrow Failure, Inflammation, Pancytopenia, Pyrexia, Tonsillitis
on Feb 15, 2007 Female patient from FRANCE , 65 years of age, was diagnosed with ill-defined disorder and was treated with Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, inflammation, pancytopenia, pyrexia, tonsillitis. Progesterone dosage: Daily Dose: 100 Milligram(s). During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PIROXICAM (Daily Dose: 2 Dosage Form) (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

5157131-0 | Bone Marrow Failure, Inflammation, Pancytopenia, Pyrexia, Tonsillitis
on Apr 05, 2006 Female patient from FRANCE , 65 years of age, was diagnosed with ill-defined disorder and was treated with Progesterone (View Usage). Patient had the following side effects: bone marrow failure, inflammation, pancytopenia, pyrexia, tonsillitis. Progesterone dosage: Daily Dose: 100 Milligram(s). During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PIROXICAM (Daily Dose: 2 Dosage Form) (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

5080334-0 | Hypospadias
Patient was taking Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: hypospadias on Aug 04, 2006 from CANADA Additional patient health information: Female patient , weighting 7.86 lb, . Progesterone dosage: . During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ).

5080015-3 | Potter's Syndrome
Adverse event was reported on Aug 04, 2006 by a Female patient taking Progesterone (View Usage) (Dosage: ) . Location: CANADA , weighting 7.00 lb, Patient experienced the following unwanted or unexpected effects: potter's syndrome. During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ).

5009422-1 | Potter's Syndrome
on May 15, 2006 Female patient from CANADA , weighting 7.00 lb, was treated with Progesterone (View Usage). Patient had the following side effects: potter's syndrome. Progesterone dosage: . During the same period patient was treated with LETROZOLE (View Letrozole Review and Letrozole Label ).

4996684-X | Retinal Detachment
on May 02, 2006 Female patient from UNITED STATES , 59 years of age, was diagnosed with hypothyroidism and was treated with Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: retinal detachment. Progesterone dosage: . During the same period patient was treated with OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), PREMARIN (View Premarin Review and Premarin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), IODINE (View Iodine Review and Iodine Label ).

4974553-9 | Hepatitis
Patient was taking Progesterone (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?) on Nov 23, 2005 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with ill-defined disorder and. Progesterone dosage: Daily Oral. During the same period patient was treated with DISULONE (DAPSONE) (See Image) (View Disulone (dapsone) Review and Disulone (dapsone) Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), PROVAMES (ESTRADIOL) (View Provames (estradiol) Review and Provames (estradiol) Label ).

4945732-1 | Anaemia, Ovarian Hyperstimulation Syndrome, Proteinuria
Adverse event was reported on Mar 08, 2006 by a Female patient taking Progesterone (View Usage) (Dosage: Daily Dose: 600 Milligram(s)) was diagnosed with ill-defined disorder and. Location: HUNGARY , 33 years of age, weighting 123.5 lb, Patient had the following side effects: anaemia, ovarian hyperstimulation syndrome, proteinuria. During the same period patient was treated with HUMAN CHORIONIC GONADOTROPIN (Daily Dose: 5000 International Unit(s)) (View Human Chorionic Gonadotropin Review and Human Chorionic Gonadotropin Label ). Patient was hospitalized.

4916413-5 | Abdominal Pain, Blood Sodium Decreased, Dyspnoea, Jugular Vein Thrombosis, Local Swelling, Neck Pain, Ovarian Hyperstimulation Syndrome, Platelet Count Increased
on Feb 10, 2006 Female patient from UNITED STATES , 32 years of age, weighting 103.6 lb, was diagnosed with luteal phase deficiency, ovulation induction, in vitro fertilisation, infertility (What is infertility?) and was treated with Progesterone (View Usage). After Progesterone was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood sodium decreased, dyspnoea, jugular vein thrombosis, local swelling, neck pain, ovarian hyperstimulation syndrome, platelet count increased. Progesterone dosage: Daily Dose: 600 Milligram(s). During the same period patient was treated with PREGNYL (Daily Dose: 10000 International Unit(s) Once) (View Pregnyl Review and Pregnyl Label ), ORAL CONTRACEPTIVES NOS (View Oral Contraceptives Nos Review and Oral Contraceptives Nos Label ), LEUPROLIDE ACETATE (Daily Dose: .5 Milligram(s)) (View Leuprolide Acetate Review and Leuprolide Acetate Label ), UROFOLLITROPIN (Daily Dose: 75 International Unit(s)) (View Urofollitropin Review and Urofollitropin Label ), MENOTROPINS (Daily Dose: 75 International Unit(s)) (View Menotropins Review and Menotropins Label ). Patient was hospitalized.